These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 19020767)

  • 21. Combined evaluation of dihydropyrimidine dehydrogenase and thymidine phosphorylate mRNA levels in tumor predicts the histopathological effect of 5-fluorouracil-based chemoradiotherapy.
    Tateishi Y; Tatemoto Y; Ohno S; Morishita K; Ueta E; Yamamoto T
    Cancer Lett; 2009 Feb; 274(2):187-93. PubMed ID: 18986760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
    Ichikawa W; Uetake H; Shirota Y; Yamada H; Nishi N; Nihei Z; Sugihara K; Hirayama R
    Clin Cancer Res; 2003 Feb; 9(2):786-91. PubMed ID: 12576451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in tumor tissues and the efficacy of 5-fluorouracil in patients with non-small-cell lung cancer.
    Shintani Y; Ohta M; Hirabayashi H; Tanaka H; Iuchi K; Nakagawa K; Maeda H; Kido T; Miyoshi S; Matsuda H
    Lung Cancer; 2004 Aug; 45(2):189-96. PubMed ID: 15246190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thymidine phosphorylase mRNA level predicts survival of patients with advanced oropharyngeal cancer.
    Ijuin T; Nibu K; Doi K; Inoue H; Saitoh M; Ohtsuki N; Makino K; Amatsu M
    Acta Otolaryngol; 2007 Mar; 127(3):305-11. PubMed ID: 17364369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity.
    Miyoshi T; Kondo K; Fujino H; Takahashi Y; Sawada N; Sakiyama S; Tsuyuguchi M; Kimura S; Sumitomo M; Monden Y
    Anticancer Res; 2005; 25(2A):923-30. PubMed ID: 15868929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro sensitivity to platinum-derived drugs is associated with expression of thymidylate synthase and dihydropyrimidine dehydrogenase in human lung cancer.
    Takizawa M; Kawakami K; Obata T; Matsumoto I; Ohta Y; Oda M; Sasaki T; Watanabe G
    Oncol Rep; 2006 Jun; 15(6):1533-9. PubMed ID: 16685392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
    Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
    Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymidylate synthetase and dihydropyrimidine dehydrogenase levels in gastric cancer.
    Ishikawa Y; Kubota T; Otani Y; Watanabe M; Teramoto T; Kumai K; Takechi T; Okabe H; Fukushima M; Kitajima M
    Anticancer Res; 1999; 19(6C):5635-40. PubMed ID: 10697632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The discrepancy in thymidylate synthase and dihydropyrimidine dehydrogenase expression depending on measurement methodologies in stage 4 gastric cancer.
    Akamoto S; Usuki H; Haba R; Kakinoki K; Okano K; Izuishi K; Wakabayashi H; Suzuki Y
    Hepatogastroenterology; 2008; 55(86-87):1882-6. PubMed ID: 19102414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between gene expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in primary cancer cells isolated from malignant ascites.
    Wang T; Wang L; Qian X; Yu L; Ding Y; Liu B
    Cancer Invest; 2011 Feb; 29(2):130-6. PubMed ID: 21210725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in thymoma.
    Sasaki H; Fukai I; Kiriyama M; Kaji M; Yano M; Yamakawa Y; Fujii Y
    Surg Today; 2003; 33(2):83-8. PubMed ID: 12616366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, and orotate phosphoribosyl transferase in prostate cancer.
    Miyoshi Y; Uemura H; Ishiguro H; Kitamura H; Nomura N; Danenberg PV; Kubota Y
    Prostate Cancer Prostatic Dis; 2005; 8(3):260-5. PubMed ID: 15999119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test.
    Kakimoto M; Uetake H; Osanai T; Shirota Y; Takagi Y; Takeshita E; Toriya Y; Danenberg K; Danenberg PV; Sugihara K
    Cancer Lett; 2005 Jun; 223(1):103-11. PubMed ID: 15890242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer.
    Fakhrejahani E; Miyamoto A; Tanigawa N
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):437-46. PubMed ID: 17377791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation between clinical pathologic factors and enzymatic activity of orotate Phosphoribosyl transferase (OPRT), Dihydropyrimidine dehydrogenase (DPD) and Thymidylate synthase (TS) in colorectal cancer].
    Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Kanazawa Y; Shirakawa T; Ohkawa K; Koizumi M; Ohaki Y; Yamashita K; Tajiri T
    Gan To Kagaku Ryoho; 2006 Jun; 33(6):789-93. PubMed ID: 16770098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase mRNA expression correlate with prolonged survival in resected non-small-cell lung cancer.
    Grimminger PP; Schneider PM; Metzger R; Vallböhmer D; Hölscher AH; Danenberg PV; Brabender J
    Clin Lung Cancer; 2010 Sep; 11(5):328-34. PubMed ID: 20837458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-fluorouracil-related gene expression levels in primary colorectal cancer and corresponding liver metastasis.
    Kuramochi H; Hayashi K; Uchida K; Miyakura S; Shimizu D; Vallbohmer D; Park S; Danenberg KD; Takasaki K; Danenberg PV
    Int J Cancer; 2006 Aug; 119(3):522-6. PubMed ID: 16572420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the mRNA expression levels of thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD) and orotate phosphoribosyl transferase (OPRT) in liver metastases from colorectal cancer.
    Yamane T; Seshimo A; Kameoka S
    Hepatogastroenterology; 2013; 60(122):291-5. PubMed ID: 22945388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of enzyme-linked immunosorbent assays for thymidylate synthase and dihydropyriminide dehydrogenase in cancer tissues.
    Kurebayashi J; Yamamoto Y; Udagawa K; Okubo S; Fukushima M; Sonoo H
    Oncol Rep; 2004 May; 11(5):973-9. PubMed ID: 15069534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Correlation between clinical pathophysiologic factors and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer].
    Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Komiyama H; Okano M
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):413-20. PubMed ID: 11915731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.